About 1% of the breast and ovarian Spanish families testing negative forBRCA1andBRCA2are carriers ofRAD51Dpathogenic variants-Reference-Cited by-同舟云学术

About 1% of the breast and ovarian Spanish families testing negative forBRCA1andBRCA2are carriers ofRAD51Dpathogenic variants

Published:2013-11-07 Issue:9 Volume:134 Page:2088-2097
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Gutiérrez-Enríquez Sara¹,Bonache Sandra¹²,Ruíz de Garibay Gorka³,Osorio Ana⁴⁵,Santamariña Marta⁶,Ramón y Cajal Teresa⁷,Esteban-Cardeñosa Eva⁸,Tenés Anna¹,Yanowsky Kira⁴⁵,Barroso Alicia⁴⁵,Montalban Gemma¹,Blanco Ana⁹,Cornet Mònica¹⁰,Gadea Neus¹¹,Infante Mar⁸,Caldés Trinidad³,Díaz-Rubio Eduardo¹²,Balmaña Judith¹³,Lasa Adriana¹⁰,Vega Ana⁹,Benítez Javier⁴⁵,de la Hoya Miguel³,Diez Orland¹²¹⁴

Affiliation:

1. Oncogenetics Group Vall d'Hebron Institute of Oncology (VHIO); Universitat Autonoma de Barcelona; Barcelona Spain

2. Oncogenetics Group; Vall d'Hebron Research Institute (VHIR) and Universitat Autonoma de Barcelona; Barcelona Spain

3. Laboratorio de Oncología Molecular; Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico San Carlos; Madrid Spain

4. Human Genetics Group Human Cancer Genetics Programme; Spanish National Cancer Centre (CNIO); Madrid Spain

5. Centre for Biomedical Network Research on Rare Diseases (CIBERER); Madrid Spain

6. Grupo de Medicina Xenómica-USC; University of Santiago de Compostela, CIBERER, IDIS; Santiago de Compostela Spain

7. Medical Oncology Department; Santa Creu i Sant Pau Hospital; Barcelona Spain

8. Instituto de Biología y Genética Molecular (UVa-CSIC); Genética del Cáncer; Valladolid Spain

9. Fundación Pública Galega de Medicina Xenómica-SERGAS; Grupo de Medicina Xenómica, CIBERER, IDIS; Santiago de Compostela Spain

10. Genetics Department; CIBERER U-705, Santa Creu i Sant Pau Hospital; Barcelona Spain

11. Medical Oncology Department; University Hospital of Vall d'Hebron; Barcelona Spain

12. Servicio de Oncología Médica; Hospital Clínico San Carlos; Madrid Spain

13. Medical Oncology Department; University Hospital of Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autonoma de Barcelona; Barcelona Spain

14. Oncogenetics Group; University Hospital of Vall d'Hebron; Barcelona Spain

Funder

Acciï¿½n Cooperativa y Colaborativa Intramural-CIBER2012

European Regional Development FEDER Funds

Fondo de Investigaciï¿½n Sanitaria (FIS)

Intrasalud

Miguel Servet program, Spanish Carlos III Health Institute

Mutua Madrileï¿½a Foundation (FMMA)

SAF2010-20493

Xunta de Galicia

Publisher

Wiley